CA Patent

CA3106124A1 — Chemical process for preparing phenylpiperidinyl indole derivatives

Assigned to Novartis AG · Expires 2020-01-23 · 6y expired

What this patent protects

The present invention relates to a method of synthesizing a compound of formula (I) also referred to as 4-((2S,4S)-(4-ethoxy-1 -((5-methoxy-7-me thyl-1 /-/-indol-4-yl)methyppiperidin-2-yl) )benzoic acid, or a pharmaceutically acceptable salt thereof, and/or intermediates thereof,…

USPTO Abstract

The present invention relates to a method of synthesizing a compound of formula (I) also referred to as 4-((2S,4S)-(4-ethoxy-1 -((5-methoxy-7-me thyl-1 /-/-indol-4-yl)methyppiperidin-2-yl) )benzoic acid, or a pharmaceutically acceptable salt thereof, and/or intermediates thereof, their use as pharmaceuticals and pharmaceutical compositions and the use of intermediates for preparing a compound of formula (I), or a pharmaceutically acceptable salt thereof.

Drugs covered by this patent

Patent Metadata

Patent number
CA3106124A1
Jurisdiction
CA
Classification
—
Expires
2020-01-23
Drug substance claim
No
Drug product claim
No
Assignee
Novartis AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.